Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for BioLife Solutions, Inc. (BLFS : NSDQ)

• Company Description    BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on their proprietary bio-packaging technology and a patented understanding of the mechanism of cellular damage and death, these products enable the biotechnology and medical community to address a growing problem that exists today. Number of Employees: 437

• Price / Volume Information    Yesterday's Closing Price: $12.86 Daily Weekly Monthly 20 Day Moving Average: 572,701 shares Shares Outstanding: 42.41 (millions) Market Capitalization: $545.39 (millions) Beta: 2.01 52 Week High: $60.67 52 Week Low: $10.40 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -4.60% 7.44% 12 Week -45.58% -40.17% Year To Date -65.49% -60.36%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 3303 MONTE VILLA PARKWAY SUITE 310 - BOTHELL,WA 98021 USA ph: 425-402-1400 fax: 425-402-1433 rdegreef@biolifesolutions.com http://www.biolifesolutions.com

• General Corporate Information    Officers Michael Rice - Chief Executive Officer Troy Wichterman - Chief Financial Officer Joseph Schick - Director Rachel Ellingson - Director Joydeep Goswami - Director Peer Information BioLife Solutions, Inc. (BJCT) BioLife Solutions, Inc. (CADMQ) BioLife Solutions, Inc. (APNO) BioLife Solutions, Inc. (UPDC) BioLife Solutions, Inc. (IMTIQ) BioLife Solutions, Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 09062W204 SIC: 3845 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/11/22 Share - Related Items Shares Outstanding: 42.41 Most Recent Split Date: 1.00 (0.07:1) Beta: 2.01 Market Capitalization: $545.39 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.09 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.38 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 10.00% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/11/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.14 Price/Cash Flow: - Price / Sales: 3.94 EPS Growth vs. Year Ago Period: -2,000.00% vs. Previous Quarter: 40.63% Sales Growth vs. Year Ago Period: 114.99% vs. Previous Quarter: -2.91% ROE 03/31/22 - -6.24 12/31/21 - -5.19 09/30/21 - -2.39 ROA 03/31/22 - -5.45 12/31/21 - -4.51 09/30/21 - -2.08 Current Ratio 03/31/22 - 3.39 12/31/21 - 3.12 09/30/21 - 3.65 Quick Ratio 03/31/22 - 2.53 12/31/21 - 2.41 09/30/21 - 2.82 Operating Margin 03/31/22 - -21.41 12/31/21 - -17.75 09/30/21 - -8.38 Net Margin 03/31/22 - -10.35 12/31/21 - -7.04 09/30/21 - 4.87 Pre-Tax Margin 03/31/22 - -24.76 12/31/21 - -23.29 09/30/21 - -16.67 Book Value 03/31/22 - 11.28 12/31/21 - 11.80 09/30/21 - 12.02 Inventory Turnover 03/31/22 - 3.47 12/31/21 - 3.44 09/30/21 - 2.93 Debt-to-Equity 03/31/22 - 0.01 12/31/21 - 0.01 09/30/21 - 0.01 Debt-to-Capital 03/31/22 - 1.35 12/31/21 - 1.36 09/30/21 - 1.30

Powered by Zacks Investment Research ©